| ASSET | YEARS | % RETURN |
|---|---|---|
Cemtrex (CETX) | 2004-2007 | 91,089,793.35% |
India Globalization Capital (IGC) | 2004-2007 | 9,833,233.33% |
OPTIMIZERx (OPRX) | 2004-2007 | 7,499,900% |
NovaBay Pharmaceuticals (NBY) | 2004-2007 | 6,251,427.79% |
Taoping (TAOP) | 2004-2007 | 2,040,036.01% |
Archrock (AROC) | 2004-2007 | 1,028,353.49% |
Perspective Therapeutics (CATX) | 2004-2007 | 669,900% |
Flotek Industries (FTK) | 2004-2007 | 578,081.82% |
Alaunos Therapeutics (TCRT) | 2004-2007 | 505,614.29% |
Danaos (DAC) | 2004-2007 | 363,012.35% |
Lixte Biotechnology (LIXT) | 2004-2007 | 299,900% |
Ring Energy (REI) | 2004-2007 | 263,900% |
TherapeuticsMD (TXMD) | 2004-2007 | 224,344.46% |
Smart Powerr (CREG) | 2004-2007 | 186,824.01% |
ProMIS Neurosciences (PMN) | 2004-2007 | 169,526.17% |
Oramed Pharmaceuticals (ORMP) | 2004-2007 | 100,196.55% |
Champions Oncology (CSBR) | 2004-2007 | 85,614.29% |
Capricor Therapeutics (CAPR) | 2004-2007 | 36,566.67% |
Stabilis Solutions (SLNG) | 2004-2007 | 17,424.64% |
Broadwind Energy (BWEN) | 2004-2007 | 17,060.69% |
Universal Insurance (UVE) | 2004-2007 | 16,601.2% |
TG Therapeutics (TGTX) | 2004-2007 | 15,720.31% |
Opus Genetics (IRD) | 2004-2007 | 10,700% |
Hudbay Minerals (HBM) | 2004-2007 | 8,248.63% |
Expedia (EXPE) | 2004-2007 | 7,721.78% |
